Review effective treatment strategies for chronic rhinosinusitis (CRS) in this new three-part on-demand series.
These short-burst videos (about 45 to 50 minutes each) will cover the latest research around the diagnosis, treatment and management of CRS with and without nasal polyps, with an emphasis on the latest evidence-based information on diagnostic tools and treatments.
Course Director
Justin Bailey, MD
Director of the Procedures Institute and Director of Research and Scholarship for Full Circle Health in Boise, Idaho.
Faculty
Joseph K, Han, MD, FARS, FAAAAI
Professor, Vice Chair of Clinical Affairs and Administration; Chief, Division of Allergy Department of Otolaryngology & Head and Neck Surgery Eastern Virginia Medical School
Anju T. Peters, MD, MSCI
Professor of Medicine Division of Allergy and Immunology; Director, Center for Clinical Research Northwestern University Clinical and Translational Sciences Institute (NUCATS)
Bradford Woodworth, MD, FACS
Professor of Otolaryngology at the University of Alabama at Birmingham.
At the end of this activity, you will be able to:
This activity is supported by an educational grant from OptiNose. OptiNose has not had input or editorial control over the content of this activity.
The AAFP has reviewed Chronic Rhinosinusitis: Are You Diagnosing and Treating Your Patients Correctly? and deemed it acceptable for up to 2.25 Enduring Materials, Self-Study AAFP Prescribed credits. Term of Approval is from 1/15/2025 to 1/15/2026. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 Credits™ toward the AMA Physician's Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed credit, not as Category 1.
CME activities approved for AAFP credit are recognized by the AOA as equivalent to AOA Category 2 credit.